Vaccines for Fertility Regulation

Opening of the symposium; J. BARZELATTO, Background and objectives; G. L. ADA and P. D. GRIFFIN, The process of reproduction in humans - antigens for vaccine development; G. L. ADA and P. D. GRIFFIN, Animal models for assessing the safety and efficacy of antifertility vaccines; P. D. GRIFFIN and A. G. HENDRICKX, An overview of the immune system; R. LOBLAY and A. BASTEN, Antigens and antigen presentation in relation to vaccine development; G. I. ADA, Assays for relevant human immune responses; A. BASTEN et al, Endocrinological hazards associated with human immunization with self or self-like antigens; T. CHARD and R. J. S. HO WELL, Immunological hazards associated with human immunization with self or self-like antigens; N. ROSE et al, Clinical parameters in pre- and post-registration assessment of vaccine safety and efficacy; W. R. JONES and A. J. BEALE, Issues relevant to other vaccination programmes or proposed other vaccination programmes; G. I. ADA and A. J. BEALE, Quality assurance of vaccines; P. SIZARET and D. I. MAGRATH, Regulatory aspects of vaccine development; J. C. W. WEBER, Legal and ethical aspects of development and use of fertility regulating vaccines; R. J. COOK and B. DICKINS, Social aspects relating to the introduction of a birth control vaccine; M. CONCEPCION et al, Chairman's summary: present status and future prospects of antifertility vaccines; N. A. MITCHISON, Report of the symposium Points to consider in the assessment of the safety and efficacy of vaccines to regulate fertility